Skip to main content
Total HealthSupply
Ondansetron Injection, USP, 4 mg / 2 mL (2 mg / mL) Multiple-Dose Vial
Available to order

Ondansetron Injection, USP, 4 mg / 2 mL (2 mg / mL) Multiple-Dose Vial

SKU APO 60505613005

$21.10

Packaging: 25 Vials per Carton. Confirm the selling unit with customer care before ordering if unclear.

Purchase options

Request quote
Brand
Apotex Inc.

Categories

Product details

Product Specifications

Specification Details
Manufacturer / Brand Apotex Corp
Manufacturer # / SKU 60505613005
NDC Number 60505-6130-05
Active Ingredient Ondansetron Hydrochloride
Strength 4 mg / 2 mL (2 mg / mL)
Volume per Unit 2 mL
Container Type Multiple-Dose Vial (MDV)
Formulation Sterile solution with Methylparaben/Propylparaben
Route of Admin Intravenous (IV) or Intramuscular (IM)
Packaging 25 Vials per Carton
Latex Content Not made with natural rubber latex

Key Features

  • Proven Efficacy: Gold standard therapy for managing highly emetogenic chemotherapy-induced nausea and vomiting (CINV).

  • Multiple-Dose Convenience: The MDV format is ideal for clinical settings where weight-based pediatric dosing or lower adult doses are required across multiple patients.

  • Rapid Action: Provides fast onset of anti-emetic effects when administered via IV bolus or IM injection.

  • Preserved Formula: Contains antimicrobial preservatives to maintain sterility during multiple entries into the vial.

  • Cost-Effective Generic: Offers the same therapeutic efficacy as brand-name Zofran® at a more accessible price point for healthcare facilities.

Clinical Applications

  • Chemotherapy Support: Prevention of nausea and vomiting associated with initial and repeat courses of emetogenic cancer therapy.

  • Surgical Recovery: Prevention and treatment of postoperative nausea and vomiting (PONV) in adult and pediatric patients.

  • Radiation Therapy: Management of nausea in patients receiving total body irradiation or localized abdominal radiation.

  • Off-Label Use: Often used in emergency departments for intractable vomiting associated with gastroenteritis.

⚠️ Safety Alert: QT Prolongation. Ondansetron can cause dose-dependent prolongation of the QT interval. Avoid in patients with congenital long QT syndrome.

⚠️ Usage Note: For IV administration, it may be given undiluted over 2 to 5 minutes or diluted in 50 mL of compatible fluid and infused over 15 minutes.

⚠️ Contraindications: Contraindicated in patients with known hypersensitivity to ondansetron or any component of the formulation. Concomitant use with apomorphine is contraindicated.